Here are five quick points:
1. The company’s revenue grew 41 percent in the first halve of the year over the same period last year. The company’s revenue was up 354 percent in the second quarter.
2. United States revenue was up 52 percent and represented 77 percent of global revenue.
3. Revenue increased 14 percent outside of the United States, which was 23 percent of global revenue.
4 France is the company’s second direct market and reported 42 percent growth in the second quarter; in the first quarter the French market reported 36 percent growth.
5. There were 3,716 PediGuard units sold in the first half of 2015, compared with 3,008 sold in the first half of last year.
6. In the United States, 1,923 units were sold, which was 52 percent of units sold.
More articles on orthopedic devices:
K2M launches 6 new spine products in Singapore & Hong Kong—5 key notes
ConforMIS closes IPO: 5 things to know
Are medical device companies ready to share risk? 7 key trends
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
